Medlab Clinical Limited (ASX:MDC)

Sean Hall
CEO
Market Cap (AUD): 54.75M
Sector: Health Care
Last Trade (AUD): 0.155 +-0 (+-3.13%)
Tab Bar

1. About

Medlab Clinical Limited (ASX:MDC) is a biotechnology company building products that are scientifically optimised for a better life, specialising in oncology and enhanced drug delivery.

Medlab has a portfolio of novel cannabinoid-based assets enhanced by its leading drug delivery platform. The Company's lead drug candidate, NanaBis, is an opioid alternative for cancer-induced pain management. 

Core to Medlab's value proposition is NanoCelle, the Company's patented sub-micron drug delivery platform that vastly improves drug solubility issues and enables faster absorption and metabolism of active ingredients. NanoCelle underpins the Company's growth strategy by providing near-term partnering opportunities while enhancing its pharma portfolio. 

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk